Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Centenarian clocks: epigenetic clocks for validating claims of exceptional longevity.
Dec E, Clement J, Cheng K, Church GM, Fossel MB, Rehkopf DH, Rosero-Bixby L, Kobor MS, Lin DT, Lu AT, Fei Z, Guo W, Chew YC, Yang X, Putra SED, Reiner AP, Correa A, Vilalta A, Pirazzini C, Passarino G, Monti D, Arosio B, Garagnani P, Franceschi C, Horvath S. Dec E, et al. Among authors: vilalta a. Geroscience. 2023 Jun;45(3):1817-1835. doi: 10.1007/s11357-023-00731-7. Epub 2023 Mar 25. Geroscience. 2023. PMID: 36964402 Free PMC article.
Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A, Ruiz R, Sanchez-Varo R, García-Revilla J, Yang Y, Jimenez-Ferrer I, Paulus A, Wennström M, Vilalta A, Allendorf D, Davila JC, Stegmayr J, Jiménez S, Roca-Ceballos MA, Navarro-Garrido V, Swanberg M, Hsieh CL, Real LM, Englund E, Linse S, Leffler H, Nilsson UJ, Brown GC, Gutierrez A, Vitorica J, Venero JL, Deierborg T. Boza-Serrano A, et al. Among authors: vilalta a. Acta Neuropathol. 2023 Apr;145(4):509-510. doi: 10.1007/s00401-023-02549-1. Acta Neuropathol. 2023. PMID: 36790609 Free PMC article. No abstract available.
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.
Köhler W, Engelen M, Eichler F, Lachmann R, Fatemi A, Sampson J, Salsano E, Gamez J, Molnar MJ, Pascual S, Rovira M, Vilà A, Pina G, Martín-Ugarte I, Mantilla A, Pizcueta P, Rodríguez-Pascau L, Traver E, Vilalta A, Pascual M, Martinell M, Meya U, Mochel F; ADVANCE Study Group. Köhler W, et al. Among authors: vilalta a. Lancet Neurol. 2023 Feb;22(2):127-136. doi: 10.1016/S1474-4422(22)00495-1. Lancet Neurol. 2023. PMID: 36681445 Clinical Trial.
Safety and Performance of a New Burr Hole Covering Device: Results of the Multicenter COVER Registry.
Asencio-Cortés C, Villalba G, De Vilalta Á, Serrano L, Álvarez-Holzapfel MJ, Montes-Graciano G, Málaga X, Muñoz-Hernandez F, Gabarrós A. Asencio-Cortés C, et al. Among authors: de vilalta a. J Neurol Surg A Cent Eur Neurosurg. 2023 Sep;84(5):445-454. doi: 10.1055/a-1883-0344. Epub 2022 Jun 23. J Neurol Surg A Cent Eur Neurosurg. 2023. PMID: 35738392 Free PMC article.
107 results